MENU

Belgium: No Freedom of Choice in Vaccination, top EU Health Official Insists

15 Nov, 2018
, Source:

There is no freedom of choice when it comes to vaccination because it involves putting other people’s health at risk, a top EU health official has warned, adding that ongoing debate in Italy about inoculations is verging “on the absurd”.

As a debate continues to rage in Italy about freedom of choice in vaccination, Martin Seychell, the European Commission’s deputy director-general for health and food safety said last week that it “is verging on the absurd, false debate”.

“Because the issue is, if I make a decision for whatever reason to refuse vaccination, I am somehow giving myself the right to transmit a disease,” he said.

Speaking at the “Active Citizens in Europe advocate for vaccination” event in the European Parliament on 7 November, Seychell noted that the decision not to vaccinate is not a “right”, particularly with vulnerable people “who cannot be vaccinated for whatever reason or who are immuno-compromised”.

The EU official also highlighted the positive role of vaccination that goes much deeper than saving lives, citing its prevention of “suffering, illness, handicaps, and also enhances economic and social productivity”.

“Vaccination reduces disease-specific treatment costs by reducing the incidents for example of primary infections, we can also, therefore, have an impact on secondary infections also liked to AMR,” he added.

Parents and vaccination  

Independent MEP David Borrelli, who hosted the event in the Parliament, said it was not easy to sway parents who have decided not to vaccinate their children.

“It’s not easy to change the minds of these parents who have already decided not to use vaccination. But we can try to understand why they are afraid of it,” the Italian politician said.

“They might not be educated about it or, on the contrary, be overwhelmed by the available information. And it’s not simple to understand who or what to believe. Yet, there are also parents who are not completely comfortable with vaccines that would like to learn more,” he added.

Borrelli said that a way to tackle misleading information on the issue is to provide better information.

“We can try to change parent’s minds by building a dialogue between them and healthcare providers, by raising awareness on vaccination safety, and by discussing benefits and risks of this method,” he emphasised.

The challenges

Seychell admitted, though, that vaccination programmes in Europe have become increasingly fragile for several reasons.

The first, he said, is the low uptake of vaccines due to hesitancy and scepticism. But he noted that the increasing cost of new vaccines also plays a role.

“Vaccines are designed for general population coverage, therefore unit price does matter, it makes a big difference whether those vaccines are affordable or not, or have to be rationed in any way.”

He noted there was a need to improve forecasting as it is not easy for companies to ramp up production.

“In this way, we will help the industry. We are not doing enough to incentivise innovation if we don’t look at the business model that is used to bring this innovation to market. We are looking into joint procurement; there are some measures. But we need better dialogue with the industry to match supply and demand.”

He said another problem was the shortage in production and supply and problems of procurement.

“Europe is no longer as self-sufficient in vaccines as it used to be or should be. I would also underline on this aspect that this has enormous security implications,” the Commission official warned.

“Do we want to be a region that is no longer self-sufficient in vaccine production of some critical vaccines? That is or would be a key vulnerability,” he warned.

Following the rise of anti-vaccination campaigns across Europe, the EU executive proposed an EU Council recommendation on strengthened cooperation of all stakeholders against vaccine-preventable diseases.

EU health ministers are expected to adopt the recommendation at a meeting in December. The Commission has said that it does not want this recommendation to remain a “piece of paper”.

The challenges

Seychell admitted, though, that vaccination programmes in Europe have become increasingly fragile for several reasons.

The first, he said, is the low uptake of vaccines due to hesitancy and scepticism. But he noted that the increasing cost of new vaccines also plays a role.

“Vaccines are designed for general population coverage, therefore unit price does matter, it makes a big difference whether those vaccines are affordable or not, or have to be rationed in any way.”

He noted there was a need to improve forecasting as it is not easy for companies to ramp up production.

“In this way, we will help the industry. We are not doing enough to incentivise innovation if we don’t look at the business model that is used to bring this innovation to market. We are looking into joint procurement; there are some measures. But we need better dialogue with the industry to match supply and demand.”

He said another problem was the shortage in production and supply and problems of procurement.

“Europe is no longer as self-sufficient in vaccines as it used to be or should be. I would also underline on this aspect that this has enormous security implications,” the Commission official warned.

“Do we want to be a region that is no longer self-sufficient in vaccine production of some critical vaccines? That is or would be a key vulnerability,” he warned.

Following the rise of anti-vaccination campaigns across Europe, the EU executive proposed an EU Council recommendation on strengthened cooperation of all stakeholders against vaccine-preventable diseases.

EU health ministers are expected to adopt the recommendation at a meeting in December. The Commission has said that it does not want this recommendation to remain a “piece of paper”.

 

 

This entry was posted on Thursday, November 15th, 2018 at 1:26 pm and is filed under Latest News.

Literature Literature archive

Baalen, S. van. 2018 Research Ethics 14(4), 1–17. https://doi.org/10.1177/1747016117750312

Videos Video archive

Key figures share their perspectives on a controversy that led to the suspension of Ebola vaccine clinical trials in Ghana.

Drs. Heidi Larson and Pauline Paterson of the Vaccine Confidence Project join episode 50 of the Public Health United podcast with Nina Martin, November 2017.

Drs. Larson and Paterson join a discussion on vaccine confidence at Hong Kong University.  September, 2015.

Subscribe to our mailing list

Click here to go to our GDPR-compliant signup form.

  • Recent Posts